Dectin-1 (CLEC7A), a C-type lectin receptor, exhibits dual roles in cancer immunity, acting as either an immunosuppressive or immunostimulatory agent depending on the tumor context and ligand availability. This evidence concerns the gene CLEC4D and cancer.